期刊文献+

小鼠肠癌RNA转染mIL-12修饰的树突细胞诱发特异性细胞毒性T淋巴细胞的研究 被引量:3

Specific activity of cytotoxic T lymphocyte in mice induced by dendritic cells after mIL-12 gene modification and murine colon carcinoma RNA transfection
下载PDF
导出
摘要 目的:研究小鼠结肠癌细胞CT-26 RNA体外转染mIL-12基因修饰的树突细胞(DC),观察其诱导特异性细胞毒性T淋巴细胞(CTL)能力。方法:小鼠骨髓细胞体外经rmGM-CSF、rmIL-4诱导培养获取DC,流式细胞仪检测其纯度;293细胞扩增携带mIL-12基因的重组腺病毒,体外转染DC;Trizol法提取CT-26细胞总RNA,应用TransM essenger体外转染mIL-12基因修饰的DC;ELISA法检测细胞上清及小鼠血液中mIL-12,LDH释放法检测小鼠体内特异性CTL活性。结果:小鼠骨髓细胞经诱导培养后,获得大量高纯度的DC,流式细胞仪检测CD11 c+的DC>90%;携带mIL-12基因重组腺病毒转染的DC细胞高表达mIL-12;CT-26细胞总RNA体外转染mIL-12基因修饰的DC后,回输小鼠,能明显提高小鼠体内mIL-12的水平,并可诱导体内生成较高水平的CTL活性,而以该RNA转染Ad-LacZ修饰DC后的对照组及RNA转染DC的对照组,可诱导机体生成中等水平的特异性CTL活性,DC、PBS对照组则均无此作用。结论:小鼠肠癌CT-26细胞总RNA转染mIL-12基因修饰的DC后,免疫接种小鼠,可提高小鼠体内m IL-12的水平,并能有效诱导机体产生较高水平的特异性CTL活性。 Objective:To investigate specific activity of cytotoxic T lymphocyte (CTL) induced by mIL-12 gene modified dendritic cells (DC) transfected with the total RNA of CT-26 (a cell line of murine carcinoma of colon). Methods : In vitro proliferation of DC from the culture of murine bone marrow was stimulated by rmGM-CSF and rmIL-4, and the purity of DC was detected by flow-cytometry. The generated DC were then modified by adenovirus with mIL-12 gene which were proliferated in 293 cells.The total RNA of CT-26 was obtained through Trizol's process, and transfected into the mIL-12 gene modified DC by TransMessenger in vitro. The levels of mIL-12 both in vitro and in vivo and the activity of CTL in vivo were estimated with enzyme linked immunosorbent assay and modified lactate dehydrogenase release assay respectively. Results:Plenty of DCs were obtained from the culture of murine bone marrow, with over 90 % of CD11c^+ cells. DC modified by mIL-12 gene could induce high level of mIL-12 both in vitro and in vivo, and the differences compared to control groups were significant (P 〈 0.01 ). Vaccination with mIL-12 gene modified DC transfected with the total colon carcinoma RNA could induce high level of specific CTL activity in vivo, and the Ad-LacZ modified DC and DC transfected with the same total RNA induced moderate level of specific CTL activity in vivo, meanwhile the level of specific CTL activity was quite low in the mice immunized with DC or phosphate buffer. Conclusion:mIL-12 gene modified DC transfected with the total RNA of tumor could raise the level of mIL-12 in mice, and could also activate specific CTL effectively.
出处 《医学研究生学报》 CAS 2007年第1期15-19,I0012,共6页 Journal of Medical Postgraduates
基金 国家自然科学基金资助项目(批准号:30470669)
关键词 白细胞介素-12 基因治疗 树突细胞 细胞毒性T淋巴细胞 Interleukin 12 Gene therapy Dendritic cells Cytotoxic T lymphocyte
  • 相关文献

参考文献11

  • 1Iwashita Y,Tahara K,Goto S,et al.A phase 1 study of autologous dendritic cell-based immunotherapy for patients with primary liver cancer[J].Cancer Immunol Immunother,2003,52(3):155-161.
  • 2Ponsaerts VFI,Van Tendeloo ZN,Beneman P.Cancer immunotherapy using RNA-loaded dedritic cells[J].Clin Exp Immunol,2003,134(3):378-384.
  • 3MILler G,Bleier JI,Antonescu C,et al.Natural killer cell depletion confounds the antitumor mechanism of endogenous IL-12 overexpression[J].Int J Cancer,2004,110(3):395-402.
  • 4Satoh Y,Esche C,Gambotto A,et al.Local administration of IL-12 transfected dedritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice[J].J Exp Ther Oncol,2002,2(6):337-349.
  • 5Mittal S,Bett AJ,Prevec L,et al.Foreign gene expression by human adenovirus type-5based vectors studied using firefly luciferase and bacterial beta galactosidase gene as reporters[J].Virology,1995,210(1):226-230.
  • 6陈丙莺,马建吟,黄钦田,尤丽芬.简易自然杀伤试验——LDH释放改良法[J].上海免疫学杂志,1989,9(4):218-219. 被引量:104
  • 7Wigginton J,Gruys E,Geiselhart L.IFN-gama and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy[J].J Clin Invest,2001,108(1):51-62.
  • 8Zitvogel L,Tahara H,Cai Q,et al.Consgtruction and characterization of retroviral vectors expression biologically active human interleukin-12[J].Human Gene Ther,1994,5(12):1493-1499.
  • 9严林,潘运龙.白细胞介素-12抑制肿瘤血管生成的研究进展[J].医学研究生学报,2005,18(3):242-245. 被引量:5
  • 10Ribas A,Amarnani SN,Buga GM,et al.Immunosupressive effects of interleukin-12 coexpression in melanoma antigen gene-modified dendritic cell vaccines[J].Cancer Gene Ther,2002,9(11):875-883.

二级参考文献21

  • 1Vizler C, Rosato A, Calderazzo F et al. Therapeutic effect of interleukin-12 on mouse haemangiosarcomas is not associated with an increased anti-tumor cytotoxic T-lymphocyte activity [J]. Br J Cancer, 1998, 77 (4):656-662.
  • 2Kanegane C, Sgadari C, Kanegane H et al. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12 [J]. J Leukoc Biol, 1998, 64(3):384-392.
  • 3Li S, Zhang X, Xia X. Regression of tumor growth and induction of long-term antitumor memory by interleukin-12 electro-gene theprapy [J]. J Natl Cancer Inst, 2002, 94(10):762-768.
  • 4Dias S, Boyd R, Balkwill F. IL-12 regulates VEGF and MMPs in a murine breast cancer model[J]. Int J Cancer, 1998, 78(3):361-365.
  • 5Duda DG, Sunamura M, Lozonschi L et al. Direct in vitro evidence and in vivo analysis of the antiangiogenesis effects of interleukin-12 [J]. Cancer Res, 2000, 60(4):1111-1116.
  • 6Nanni P, Rossi I, De Giovanni C et al. Interleukin-12 gene therapy of MHC-negative murine melanoma metastases [J]. Cancer Res, 1995, 58(6):1225-1230.
  • 7Tasaki K, Yoshida Y, Maeda T et al. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells [J].Cancer Gene Ther, 2000, 7(2):247-254.
  • 8Andrews KJ, Ribas A, Butterfield LH et al. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocelluar carcinoma model is not dependent on CD1-restricted natural killer T cells [J].Cancer Res, 2000, 60(22):6457-6464.
  • 9Boggio K, Di Carlo E, Rovero S et al. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice [J].Cancer Res, 2000, 60(2):359-364.
  • 10Portielje JE, Kruit WH, Schuler M et al. Phase 1 study of subcutaneously administered recombinant human interleukin-12 in patients with advanced renal cell cancer [J]. Clin Cancer Res,1999,5(12):3983-3989.

共引文献107

同被引文献31

引证文献3

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部